PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo

Hye-Jung Ihn(Kyungpook National University), Eui Kyun Park(Kyungpook National University)

International Journal of Molecular Sciences

February 15, 2021

10.3390/ijms22041915

Cited by 12

Related Papers

Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways

|BMB Reports|2017|18

Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway

|PLoS ONE|2015|16

The guanine nucleotide exchange factor DOCK5 negatively regulates osteoblast differentiation and BMP2-induced bone regeneration via the MKK3/6 and p38 signaling pathways

|Experimental & Molecular Medicine|2025|5

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption

|Animal Cells and Systems|2023|3

Glycinamide Facilitates Nanocomplex Formation and Functions Synergistically with Bone Morphogenetic Protein 2 to Promote Osteoblast Differentiation In Vitro and Bone Regeneration in a Mouse Calvarial Defect Model

|Tissue Engineering and Regenerative Medicine|2024|2